Se espera que el mercado mundial de tratamiento de enfermedades musculoesqueléticas alcance los 5.730,8 millones de dólares en 2025 desde los 3.837,9 millones de dólares de 2017. Se estima que el mercado de tratamiento de enfermedades musculoesqueléticas crecerá con una tasa compuesta anual del 5,3% entre 2018 y 2025.
América del Norte es el mercado geográfico más grande y se espera que sea el mayor generador de ingresos durante el período de pronóstico, mientras que se espera que el mercado experimente un crecimiento a un ritmo significativo. en la región de Asia Pacífico (APAC) durante el período de pronóstico. Se espera que la mayor parte de la demanda se genere en los países mencionados anteriormente. Además, es probable que factores como el creciente enfoque de los actores de la industria global en India y Japón y los fondos en China impulsen el crecimiento del mercado.
;Mercados regionales lucrativos
Perspectivas del mercado
Prevalencia creciente de trastornos musculoesqueléticos
Los trastornos musculoesqueléticos son asociados con deportes, lesiones ocupacionales y disfunciones relacionadas con la edad. Algunas de las enfermedades musculoesqueléticas más comunes son dolor de espalda, artritis reumatoide, osteoartritis, osteoporosis, artritis séptica, gota, miastenia gravis, lupus eritematoso sistémico (LES) y otras. El sistema musculoesquelético es el diagnóstico y tratamiento de todas las afecciones agudas y crónicas que afectan al sistema musculoesquelético, es decir, músculos, huesos, tendones, articulaciones y ligamentos y el tratamiento de lesiones no quirúrgicas del sistema musculoesquelético. La creciente prevalencia de enfermedades musculoesqueléticas son los principales factores del crecimiento del mercado. Por ejemplo, según la Arthritis Foundation, en 2017, aproximadamente 54 millones de adultos fueron diagnosticados con artritis. Casi 300.000 bebés y niños padecen artritis o una enfermedad reumática. El tipo común de artritis es la osteoartritis, que afecta aproximadamente a 31 millones de estadounidenses. Para finales de 2040, se espera que el número de personas que tendrán artritis diagnosticada por un médico supere los 78 millones. Según el informe publicado en 2018 de Healthline Media, la artritis reumatoide (AR) afecta a 41 de cada 100.000 personas al año. Aproximadamente, 1,3 millones de estadounidenses padecen AR. Las mujeres tienen entre dos y tres veces más probabilidades de padecer AR que los hombres. El riesgo de desarrollar AR a lo largo de la vida es del 3,6% para las mujeres y del 1,7% para los hombres. Sin embargo, la AR puede aparecer a cualquier edad, incluso los niños pequeños pueden contraerla. El tabaquismo es el factor de riesgo más asociado a la aparición de AR en los pacientes. Se dice que un historial de tabaquismo aumenta el riesgo de desarrollar AR hasta en un 2,4 %.
Avances tecnológicos en el diagnóstico de enfermedades musculoesqueléticas
Enfermedades musculoesqueléticas El tratamiento se realiza con la ayuda de las modalidades de diagnóstico por imágenes más flexibles que tienen la capacidad de caracterizar una amplia gama de parámetros en el sujeto vivo, además de proporcionar una resolución espacial exquisita. Esta técnica ha sido explorada por numerosos actores del mercado para lograr una precisión notable a través de una amplia innovación en el diseño y las características del producto. Varios avances tecnológicos recientes están marcados en la evolución de las técnicas de tratamiento de enfermedades musculoesqueléticas en los últimos años.
Por ejemplo, en junio de 2018, Konica Minolta Healthcare Americas, Inc. , lanzó el sistema de ultrasonido portátil SONIMAGE MX1, desarrollado para consultas musculoesqueléticas (MSK) y ortopédicas, orientación intervencionista y centros ambulatorios. SONIMAGE MX1 está fabricado con la potencia y la portabilidad que los médicos necesitan para realizar un diagnóstico confiable y eficiente en el punto de atención. En marzo de 2018, Philips presentó un nuevo escáner de resonancia magnética de 3 teslas llamado Ingenia Elition 3.0T en la ECR 2018 en Viena. Por lo tanto, se espera que los pasos innovadores y los avances tecnológicos emprendidos por los nuevos participantes, así como por los actores establecidos del mercado para mejorar la calidad y eficacia de las exploraciones de tratamiento de enfermedades musculoesqueléticas, favorezcan el crecimiento del mercado en los próximos años.
Disease Insights
El mercado de tratamiento de enfermedades musculoesqueléticas por enfermedad se segmenta en artritis, osteoartritis, osteoporosis, espondilitis y otras. En 2017, el segmento de artritis tuvo la mayor cuota de mercado del 43,2% del mercado de tratamiento de enfermedades musculoesqueléticas, por enfermedad. También se espera que este segmento domine el mercado en 2025 debido a que la artritis es el segmento más grande entre el segmento de enfermedades en el mercado de tratamiento de enfermedades musculoesqueléticas en 2017 y también se prevé que mantenga el mercado más grande en el año 2025 debido a la creciente prevalencia de la enfermedad en todo el mundo. Además, se prevé que el segmento de espondilitis experimente la tasa de crecimiento más rápida durante el período previsto, de 2018 a 2025.
Imaging Modality Insights
En el Según el canal de distribución, el mercado de tratamiento de enfermedades musculoesqueléticas se segmenta en tomografía computarizada, resonancia magnética, ultrasonido y otros. Se prevé que el segmento de tomografía computarizada crezca a una tasa compuesta anual del 5,4% durante el período previsto. El crecimiento del segmento de tomografía computarizada se debe principalmente a la creciente innovación de productos en el campo de la TC por parte de los actores del mercado, así como a los avances en la exploración por TC que brindan una mayor comodidad al paciente. Por otro lado, se espera que el ultrasonido experimente el crecimiento más rápido registrando una tasa compuesta anual del 5,7% en el mercado mundial de tratamiento de enfermedades musculoesqueléticas durante el período previsto.
Mercado de tratamiento de enfermedades musculoesqueléticas, por modalidad de imagen
Perspectivas estratégicas
Lanzamiento/actualización de productos y acuerdos y acuerdos. Se observó que las asociaciones son la estrategia más adoptada en la industria mundial del tratamiento de enfermedades musculoesqueléticas. A continuación se enumeran algunas de las aprobaciones de productos y asociaciones realizadas por los actores del mercado;
2018: en septiembre, Royal Philips lanzó el Ingenia Ambition X 1.5T MR. El producto es el último avance en la cartera de MRI de Ingenia, que comprende sistemas de MRI totalmente digitales, informática sanitaria y una gama de sistemas de MRI totalmente digitales. de servicios de mantenimiento y ciclo de vida para soluciones integradas que permiten un camino más rápido, más inteligente y más sencillo para permitir un diagnóstico confiable.
2017: En noviembre, Canon Medical Systems anunció el lanzamiento del nuevo paquete para sus escáneres iSeries. La serie incluirá Aplio i700, i800 e i900, que evaluarán a los pacientes que padecen enfermedades.
2018: En enero, AllTech Medical Systems America y RSTI firmaron un acuerdo para impartir formación. El acuerdo se centra en que RSTI ofrezca un programa de capacitación en servicios de resonancia magnética en la sede de Alltech Medical Systems America en Solon, Ohio. El programa debe proporcionar un espectro completo de soluciones de servicios y cursos de capacitación en resonancia magnética.
TRATAMIENTO DE ENFERMEDADES MUSCULOSQUELÉTICAS: ndash; SEGMENTACIÓN DEL MERCADO
Por Enfermedad
- Artritis
- Osteoartritis
- Osteoporosis
- Espondilitis
- Otros
Por modalidad de imagen
- Resonancia magnética (MRI)
- Tomografía computarizada (TC)
- Ultrasonido
- Otros
Por Geografía
• América del Norte
- Estados Unidos
- Canadá
- México
• Europa
- Francia
- Alemania
- Reino Unido
• Asia Pacífico (APAC)
- China
- India
- Japón
• Medio Oriente y Asia África (MEA)
- Arabia Saudita
- Sudáfrica
- EAU
• América del Sur (SAM)
- Brasil
Perfiles de empresas
- General Electric
- Siemens AG
- CANON MEDICAL SYSTEMS CORPORATION
- Koninklijke Philips NV
- Hitachi, Ltd.
- Accuray Incorporated
- Soluciones de RM
- Alltech Medical Systems
- División Terason Teratech Corporation
- Echo-Son SA
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. General Electric
2. Koninklijke Philips N.V.
3. Siemens AG
4. Canon Medical Systems Corporation
5. Hitachi, Ltd.
6. Accuray Incorporated
7. MR Solutions
8. Alltech Medical Systems
9. Terason Division Teratech Corporation
10. Echo-Son SA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2018
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2018
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2018
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)